However, like many peptides and supplements, the reviews and feedback about AOD 9604 vary widely
C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment) Insulin-Like Growth Factor I (IGF-I) ACTH, Plasma Estrone, LC/MS/MS Estradiol, Ultrasensitive, LC/MS/MS Sex Hormone binding Globulin, Serum Pregnenolone, LC/MS Homocysteine, Cardiovascular Tri-iodothyronine Free (FT3) Thyroxine Free, Direct Dialysis (FT4) Total Testosterone, Free (Dialysis) Testosterone (calculated) Copper, Serum or Plasma Dehydroepiandrosterone (DHEA-s) Sulfate Cortisol, AM Fibrinogen Activity Hemoglobin (Hgb) A1c Thyroid Peroxidase (TPO) Antibodies Growth Hormone, Serum Prostate-Specific Antigen (PSA), Total Insulin Follicle-stimulating Hormone (FSH) and Luteinizing Hormone (LH) Progesterone, serum Prolactin, serum Thyroid-Stimulating Hormone (TSH) Dihydrotestosterone, LC/MS/MS Reverse Tri-iodothyronine (RT3) Cardio IQ Cholesterol, Total
Results from this investigation indicated that the peptide reduced over 50% body weight gain of the animals in comparison with the control. Further observation indicated heightened lipolytic activity within the adipose tissues of rats receiving AOD 9604 peptide, accompanied by an absence of notable disruptions in insulin sensitivity
Neither compound holds MHRA or EMA marketing authorisation
